世界のインフルエンザ用抗ウイルス薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Influenza Antiviral Drugs Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4366
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、118ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、インフルエンザ用抗ウイルス薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（オセルタミビル、ザナミビル、ペラミビル、アダマンタン、その他）、用途別市場規模（病院、クリニック、外科医院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・インフルエンザ用抗ウイルス薬の市場動向
・企業の競争状況、市場シェア
・インフルエンザ用抗ウイルス薬の種類別市場規模と予測2016-2027（オセルタミビル、ザナミビル、ペラミビル、アダマンタン、その他）
・インフルエンザ用抗ウイルス薬の用途別市場規模と予測2016-2027（病院、クリニック、外科医院、薬局、その他）
・インフルエンザ用抗ウイルス薬の北米市場規模2016-2027（アメリカ、カナダ）
・インフルエンザ用抗ウイルス薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・インフルエンザ用抗ウイルス薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・インフルエンザ用抗ウイルス薬の中南米市場規模2016-2027（メキシコ、ブラジル）
・インフルエンザ用抗ウイルス薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（GSK、Boehringer Ingelheim、Merck、Novartis、Beximco Pharmaceuticals、Pfizer、Roche、Johnson & Johnson、Sanofi、Cipla Limited、Natco Pharma、Seqirus、Adamas Pharmaceuticals, Inc.、Teva Pharmaceuticals、Daiichi Sankyo Company）
・結論

Market Analysis and Insights: Global Influenza Antiviral Drugs Market
The global Influenza Antiviral Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Influenza Antiviral Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Influenza Antiviral Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Influenza Antiviral Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Influenza Antiviral Drugs market.

Global Influenza Antiviral Drugs Scope and Market Size
Influenza Antiviral Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Influenza Antiviral Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Oseltamivir
Zanamivir
Peramivir
Adamantanes
Others

Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Pharmacies
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
GSK
Boehringer Ingelheim
Merck
Novartis
Beximco Pharmaceuticals
Pfizer
Roche
Johnson & Johnson
Sanofi
Cipla Limited
Natco Pharma
Seqirus
Adamas Pharmaceuticals, Inc.
Teva Pharmaceuticals
Daiichi Sankyo Company

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Influenza Antiviral Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oseltamivir
1.2.3 Zanamivir
1.2.4 Peramivir
1.2.5 Adamantanes
1.2.6 Others
1.3 Market by Application
1.3.1 Global Influenza Antiviral Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Pharmacies
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Influenza Antiviral Drugs Market Perspective (2016-2027)
2.2 Influenza Antiviral Drugs Growth Trends by Regions
2.2.1 Influenza Antiviral Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Influenza Antiviral Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Influenza Antiviral Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Influenza Antiviral Drugs Industry Dynamic
2.3.1 Influenza Antiviral Drugs Market Trends
2.3.2 Influenza Antiviral Drugs Market Drivers
2.3.3 Influenza Antiviral Drugs Market Challenges
2.3.4 Influenza Antiviral Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Influenza Antiviral Drugs Players by Revenue
3.1.1 Global Top Influenza Antiviral Drugs Players by Revenue (2016-2021)
3.1.2 Global Influenza Antiviral Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Influenza Antiviral Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Influenza Antiviral Drugs Revenue
3.4 Global Influenza Antiviral Drugs Market Concentration Ratio
3.4.1 Global Influenza Antiviral Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Influenza Antiviral Drugs Revenue in 2020
3.5 Influenza Antiviral Drugs Key Players Head office and Area Served
3.6 Key Players Influenza Antiviral Drugs Product Solution and Service
3.7 Date of Enter into Influenza Antiviral Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Influenza Antiviral Drugs Breakdown Data by Type
4.1 Global Influenza Antiviral Drugs Historic Market Size by Type (2016-2021)
4.2 Global Influenza Antiviral Drugs Forecasted Market Size by Type (2022-2027)

5 Influenza Antiviral Drugs Breakdown Data by Application
5.1 Global Influenza Antiviral Drugs Historic Market Size by Application (2016-2021)
5.2 Global Influenza Antiviral Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Influenza Antiviral Drugs Market Size (2016-2027)
6.2 North America Influenza Antiviral Drugs Market Size by Type
6.2.1 North America Influenza Antiviral Drugs Market Size by Type (2016-2021)
6.2.2 North America Influenza Antiviral Drugs Market Size by Type (2022-2027)
6.2.3 North America Influenza Antiviral Drugs Market Size by Type (2016-2027)
6.3 North America Influenza Antiviral Drugs Market Size by Application
6.3.1 North America Influenza Antiviral Drugs Market Size by Application (2016-2021)
6.3.2 North America Influenza Antiviral Drugs Market Size by Application (2022-2027)
6.3.3 North America Influenza Antiviral Drugs Market Size by Application (2016-2027)
6.4 North America Influenza Antiviral Drugs Market Size by Country
6.4.1 North America Influenza Antiviral Drugs Market Size by Country (2016-2021)
6.4.2 North America Influenza Antiviral Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Influenza Antiviral Drugs Market Size (2016-2027)
7.2 Europe Influenza Antiviral Drugs Market Size by Type
7.2.1 Europe Influenza Antiviral Drugs Market Size by Type (2016-2021)
7.2.2 Europe Influenza Antiviral Drugs Market Size by Type (2022-2027)
7.2.3 Europe Influenza Antiviral Drugs Market Size by Type (2016-2027)
7.3 Europe Influenza Antiviral Drugs Market Size by Application
7.3.1 Europe Influenza Antiviral Drugs Market Size by Application (2016-2021)
7.3.2 Europe Influenza Antiviral Drugs Market Size by Application (2022-2027)
7.3.3 Europe Influenza Antiviral Drugs Market Size by Application (2016-2027)
7.4 Europe Influenza Antiviral Drugs Market Size by Country
7.4.1 Europe Influenza Antiviral Drugs Market Size by Country (2016-2021)
7.4.2 Europe Influenza Antiviral Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Influenza Antiviral Drugs Market Size (2016-2027)
8.2 Asia-Pacific Influenza Antiviral Drugs Market Size by Type
8.2.1 Asia-Pacific Influenza Antiviral Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Influenza Antiviral Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Influenza Antiviral Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Influenza Antiviral Drugs Market Size by Application
8.3.1 Asia-Pacific Influenza Antiviral Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Influenza Antiviral Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Influenza Antiviral Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Influenza Antiviral Drugs Market Size by Region
8.4.1 Asia-Pacific Influenza Antiviral Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Influenza Antiviral Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Influenza Antiviral Drugs Market Size (2016-2027)
9.2 Latin America Influenza Antiviral Drugs Market Size by Type
9.2.1 Latin America Influenza Antiviral Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Influenza Antiviral Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Influenza Antiviral Drugs Market Size by Type (2016-2027)
9.3 Latin America Influenza Antiviral Drugs Market Size by Application
9.3.1 Latin America Influenza Antiviral Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Influenza Antiviral Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Influenza Antiviral Drugs Market Size by Application (2016-2027)
9.4 Latin America Influenza Antiviral Drugs Market Size by Country
9.4.1 Latin America Influenza Antiviral Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Influenza Antiviral Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Influenza Antiviral Drugs Market Size (2016-2027)
10.2 Middle East & Africa Influenza Antiviral Drugs Market Size by Type
10.2.1 Middle East & Africa Influenza Antiviral Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Influenza Antiviral Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Influenza Antiviral Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Influenza Antiviral Drugs Market Size by Application
10.3.1 Middle East & Africa Influenza Antiviral Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Influenza Antiviral Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Influenza Antiviral Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Influenza Antiviral Drugs Market Size by Country
10.4.1 Middle East & Africa Influenza Antiviral Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Influenza Antiviral Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 GSK Business Overview
11.1.3 GSK Influenza Antiviral Drugs Introduction
11.1.4 GSK Revenue in Influenza Antiviral Drugs Business (2016-2021)
11.1.5 GSK Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Details
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Influenza Antiviral Drugs Introduction
11.2.4 Boehringer Ingelheim Revenue in Influenza Antiviral Drugs Business (2016-2021)
11.2.5 Boehringer Ingelheim Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Influenza Antiviral Drugs Introduction
11.3.4 Merck Revenue in Influenza Antiviral Drugs Business (2016-2021)
11.3.5 Merck Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Influenza Antiviral Drugs Introduction
11.4.4 Novartis Revenue in Influenza Antiviral Drugs Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 Beximco Pharmaceuticals
11.5.1 Beximco Pharmaceuticals Company Details
11.5.2 Beximco Pharmaceuticals Business Overview
11.5.3 Beximco Pharmaceuticals Influenza Antiviral Drugs Introduction
11.5.4 Beximco Pharmaceuticals Revenue in Influenza Antiviral Drugs Business (2016-2021)
11.5.5 Beximco Pharmaceuticals Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Influenza Antiviral Drugs Introduction
11.6.4 Pfizer Revenue in Influenza Antiviral Drugs Business (2016-2021)
11.6.5 Pfizer Recent Development
11.7 Roche
11.7.1 Roche Company Details
11.7.2 Roche Business Overview
11.7.3 Roche Influenza Antiviral Drugs Introduction
11.7.4 Roche Revenue in Influenza Antiviral Drugs Business (2016-2021)
11.7.5 Roche Recent Development
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Details
11.8.2 Johnson & Johnson Business Overview
11.8.3 Johnson & Johnson Influenza Antiviral Drugs Introduction
11.8.4 Johnson & Johnson Revenue in Influenza Antiviral Drugs Business (2016-2021)
11.8.5 Johnson & Johnson Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Influenza Antiviral Drugs Introduction
11.9.4 Sanofi Revenue in Influenza Antiviral Drugs Business (2016-2021)
11.9.5 Sanofi Recent Development
11.10 Cipla Limited
11.10.1 Cipla Limited Company Details
11.10.2 Cipla Limited Business Overview
11.10.3 Cipla Limited Influenza Antiviral Drugs Introduction
11.10.4 Cipla Limited Revenue in Influenza Antiviral Drugs Business (2016-2021)
11.10.5 Cipla Limited Recent Development
11.11 Natco Pharma
11.11.1 Natco Pharma Company Details
11.11.2 Natco Pharma Business Overview
11.11.3 Natco Pharma Influenza Antiviral Drugs Introduction
11.11.4 Natco Pharma Revenue in Influenza Antiviral Drugs Business (2016-2021)
11.11.5 Natco Pharma Recent Development
11.12 Seqirus
11.12.1 Seqirus Company Details
11.12.2 Seqirus Business Overview
11.12.3 Seqirus Influenza Antiviral Drugs Introduction
11.12.4 Seqirus Revenue in Influenza Antiviral Drugs Business (2016-2021)
11.12.5 Seqirus Recent Development
11.13 Adamas Pharmaceuticals, Inc.
11.13.1 Adamas Pharmaceuticals, Inc. Company Details
11.13.2 Adamas Pharmaceuticals, Inc. Business Overview
11.13.3 Adamas Pharmaceuticals, Inc. Influenza Antiviral Drugs Introduction
11.13.4 Adamas Pharmaceuticals, Inc. Revenue in Influenza Antiviral Drugs Business (2016-2021)
11.13.5 Adamas Pharmaceuticals, Inc. Recent Development
11.14 Teva Pharmaceuticals
11.14.1 Teva Pharmaceuticals Company Details
11.14.2 Teva Pharmaceuticals Business Overview
11.14.3 Teva Pharmaceuticals Influenza Antiviral Drugs Introduction
11.14.4 Teva Pharmaceuticals Revenue in Influenza Antiviral Drugs Business (2016-2021)
11.14.5 Teva Pharmaceuticals Recent Development
11.15 Daiichi Sankyo Company
11.15.1 Daiichi Sankyo Company Company Details
11.15.2 Daiichi Sankyo Company Business Overview
11.15.3 Daiichi Sankyo Company Influenza Antiviral Drugs Introduction
11.15.4 Daiichi Sankyo Company Revenue in Influenza Antiviral Drugs Business (2016-2021)
11.15.5 Daiichi Sankyo Company Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Influenza Antiviral Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oseltamivir
Table 3. Key Players of Zanamivir
Table 4. Key Players of Peramivir
Table 5. Key Players of Adamantanes
Table 6. Key Players of Others
Table 7. Global Influenza Antiviral Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Influenza Antiviral Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Influenza Antiviral Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Influenza Antiviral Drugs Market Share by Regions (2016-2021)
Table 11. Global Influenza Antiviral Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Influenza Antiviral Drugs Market Share by Regions (2022-2027)
Table 13. Influenza Antiviral Drugs Market Trends
Table 14. Influenza Antiviral Drugs Market Drivers
Table 15. Influenza Antiviral Drugs Market Challenges
Table 16. Influenza Antiviral Drugs Market Restraints
Table 17. Global Influenza Antiviral Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Influenza Antiviral Drugs Market Share by Players (2016-2021)
Table 19. Global Top Influenza Antiviral Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Antiviral Drugs as of 2020)
Table 20. Ranking of Global Top Influenza Antiviral Drugs Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Influenza Antiviral Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Influenza Antiviral Drugs Product Solution and Service
Table 24. Date of Enter into Influenza Antiviral Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Influenza Antiviral Drugs Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Influenza Antiviral Drugs Revenue Market Share by Type (2016-2021)
Table 28. Global Influenza Antiviral Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Influenza Antiviral Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Influenza Antiviral Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Influenza Antiviral Drugs Revenue Market Share by Application (2016-2021)
Table 32. Global Influenza Antiviral Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Influenza Antiviral Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Influenza Antiviral Drugs Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Influenza Antiviral Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Influenza Antiviral Drugs Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Influenza Antiviral Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Influenza Antiviral Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Influenza Antiviral Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Influenza Antiviral Drugs Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Influenza Antiviral Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Influenza Antiviral Drugs Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Influenza Antiviral Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Influenza Antiviral Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Influenza Antiviral Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Influenza Antiviral Drugs Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Influenza Antiviral Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Influenza Antiviral Drugs Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Influenza Antiviral Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Influenza Antiviral Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Influenza Antiviral Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Influenza Antiviral Drugs Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Influenza Antiviral Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Influenza Antiviral Drugs Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Influenza Antiviral Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Influenza Antiviral Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Influenza Antiviral Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Influenza Antiviral Drugs Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Influenza Antiviral Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Influenza Antiviral Drugs Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Influenza Antiviral Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Influenza Antiviral Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Influenza Antiviral Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 64. GSK Company Details
Table 65. GSK Business Overview
Table 66. GSK Influenza Antiviral Drugs Product
Table 67. GSK Revenue in Influenza Antiviral Drugs Business (2016-2021) & (US$ Million)
Table 68. GSK Recent Development
Table 69. Boehringer Ingelheim Company Details
Table 70. Boehringer Ingelheim Business Overview
Table 71. Boehringer Ingelheim Influenza Antiviral Drugs Product
Table 72. Boehringer Ingelheim Revenue in Influenza Antiviral Drugs Business (2016-2021) & (US$ Million)
Table 73. Boehringer Ingelheim Recent Development
Table 74. Merck Company Details
Table 75. Merck Business Overview
Table 76. Merck Influenza Antiviral Drugs Product
Table 77. Merck Revenue in Influenza Antiviral Drugs Business (2016-2021) & (US$ Million)
Table 78. Merck Recent Development
Table 79. Novartis Company Details
Table 80. Novartis Business Overview
Table 81. Novartis Influenza Antiviral Drugs Product
Table 82. Novartis Revenue in Influenza Antiviral Drugs Business (2016-2021) & (US$ Million)
Table 83. Novartis Recent Development
Table 84. Beximco Pharmaceuticals Company Details
Table 85. Beximco Pharmaceuticals Business Overview
Table 86. Beximco Pharmaceuticals Influenza Antiviral Drugs Product
Table 87. Beximco Pharmaceuticals Revenue in Influenza Antiviral Drugs Business (2016-2021) & (US$ Million)
Table 88. Beximco Pharmaceuticals Recent Development
Table 89. Pfizer Company Details
Table 90. Pfizer Business Overview
Table 91. Pfizer Influenza Antiviral Drugs Product
Table 92. Pfizer Revenue in Influenza Antiviral Drugs Business (2016-2021) & (US$ Million)
Table 93. Pfizer Recent Development
Table 94. Roche Company Details
Table 95. Roche Business Overview
Table 96. Roche Influenza Antiviral Drugs Product
Table 97. Roche Revenue in Influenza Antiviral Drugs Business (2016-2021) & (US$ Million)
Table 98. Roche Recent Development
Table 99. Johnson & Johnson Company Details
Table 100. Johnson & Johnson Business Overview
Table 101. Johnson & Johnson Revenue in Influenza Antiviral Drugs Business (2016-2021) & (US$ Million)
Table 102. Johnson & Johnson Recent Development
Table 103. Sanofi Company Details
Table 104. Sanofi Business Overview
Table 105. Sanofi Influenza Antiviral Drugs Product
Table 106. Sanofi Revenue in Influenza Antiviral Drugs Business (2016-2021) & (US$ Million)
Table 107. Sanofi Recent Development
Table 108. Cipla Limited Company Details
Table 109. Cipla Limited Business Overview
Table 110. Cipla Limited Influenza Antiviral Drugs Product
Table 111. Cipla Limited Revenue in Influenza Antiviral Drugs Business (2016-2021) & (US$ Million)
Table 112. Cipla Limited Recent Development
Table 113. Natco Pharma Company Details
Table 114. Natco Pharma Business Overview
Table 115. Natco Pharma Influenza Antiviral Drugs Product
Table 116. Natco Pharma Revenue in Influenza Antiviral Drugs Business (2016-2021) & (US$ Million)
Table 117. Natco Pharma Recent Development
Table 118. Seqirus Company Details
Table 119. Seqirus Business Overview
Table 120. Seqirus Influenza Antiviral Drugs Product
Table 121. Seqirus Revenue in Influenza Antiviral Drugs Business (2016-2021) & (US$ Million)
Table 122. Seqirus Recent Development
Table 123. Adamas Pharmaceuticals, Inc. Company Details
Table 124. Adamas Pharmaceuticals, Inc. Business Overview
Table 125. Adamas Pharmaceuticals, Inc. Influenza Antiviral Drugs Product
Table 126. Adamas Pharmaceuticals, Inc. Revenue in Influenza Antiviral Drugs Business (2016-2021) & (US$ Million)
Table 127. Adamas Pharmaceuticals, Inc. Recent Development
Table 128. Teva Pharmaceuticals Company Details
Table 129. Teva Pharmaceuticals Business Overview
Table 130. Teva Pharmaceuticals Influenza Antiviral Drugs Product
Table 131. Teva Pharmaceuticals Revenue in Influenza Antiviral Drugs Business (2016-2021) & (US$ Million)
Table 132. Teva Pharmaceuticals Recent Development
Table 133. Daiichi Sankyo Company Company Details
Table 134. Daiichi Sankyo Company Business Overview
Table 135. Daiichi Sankyo Company Influenza Antiviral Drugs Product
Table 136. Daiichi Sankyo Company Revenue in Influenza Antiviral Drugs Business (2016-2021) & (US$ Million)
Table 137. Daiichi Sankyo Company Recent Development
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Influenza Antiviral Drugs Market Share by Type: 2020 VS 2027
Figure 2. Oseltamivir Features
Figure 3. Zanamivir Features
Figure 4. Peramivir Features
Figure 5. Adamantanes Features
Figure 6. Others Features
Figure 7. Global Influenza Antiviral Drugs Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Ambulatory Surgical Centers Case Studies
Figure 11. Pharmacies Case Studies
Figure 12. Others Case Studies
Figure 13. Influenza Antiviral Drugs Report Years Considered
Figure 14. Global Influenza Antiviral Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Influenza Antiviral Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Influenza Antiviral Drugs Market Share by Regions: 2020 VS 2027
Figure 17. Global Influenza Antiviral Drugs Market Share by Regions (2022-2027)
Figure 18. Global Influenza Antiviral Drugs Market Share by Players in 2020
Figure 19. Global Top Influenza Antiviral Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Antiviral Drugs as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Influenza Antiviral Drugs Revenue in 2020
Figure 21. Global Influenza Antiviral Drugs Revenue Market Share by Type (2016-2021)
Figure 22. Global Influenza Antiviral Drugs Revenue Market Share by Type (2022-2027)
Figure 23. North America Influenza Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Influenza Antiviral Drugs Market Share by Type (2016-2027)
Figure 25. North America Influenza Antiviral Drugs Market Share by Application (2016-2027)
Figure 26. North America Influenza Antiviral Drugs Market Share by Country (2016-2027)
Figure 27. United States Influenza Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Influenza Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Influenza Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Influenza Antiviral Drugs Market Share by Type (2016-2027)
Figure 31. Europe Influenza Antiviral Drugs Market Share by Application (2016-2027)
Figure 32. Europe Influenza Antiviral Drugs Market Share by Country (2016-2027)
Figure 33. Germany Influenza Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Influenza Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Influenza Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Influenza Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Influenza Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Influenza Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Influenza Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Influenza Antiviral Drugs Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Influenza Antiviral Drugs Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Influenza Antiviral Drugs Market Share by Region (2016-2027)
Figure 43. China Influenza Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Influenza Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Influenza Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Influenza Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Influenza Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Influenza Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Influenza Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Influenza Antiviral Drugs Market Share by Type (2016-2027)
Figure 51. Latin America Influenza Antiviral Drugs Market Share by Application (2016-2027)
Figure 52. Latin America Influenza Antiviral Drugs Market Share by Country (2016-2027)
Figure 53. Mexico Influenza Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Influenza Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Influenza Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Influenza Antiviral Drugs Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Influenza Antiviral Drugs Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Influenza Antiviral Drugs Market Share by Country (2016-2027)
Figure 59. Turkey Influenza Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Influenza Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Influenza Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. GSK Revenue Growth Rate in Influenza Antiviral Drugs Business (2016-2021)
Figure 63. Boehringer Ingelheim Revenue Growth Rate in Influenza Antiviral Drugs Business (2016-2021)
Figure 64. Merck Revenue Growth Rate in Influenza Antiviral Drugs Business (2016-2021)
Figure 65. Novartis Revenue Growth Rate in Influenza Antiviral Drugs Business (2016-2021)
Figure 66. Beximco Pharmaceuticals Revenue Growth Rate in Influenza Antiviral Drugs Business (2016-2021)
Figure 67. Pfizer Revenue Growth Rate in Influenza Antiviral Drugs Business (2016-2021)
Figure 68. Roche Revenue Growth Rate in Influenza Antiviral Drugs Business (2016-2021)
Figure 69. Johnson & Johnson Revenue Growth Rate in Influenza Antiviral Drugs Business (2016-2021)
Figure 70. Sanofi Revenue Growth Rate in Influenza Antiviral Drugs Business (2016-2021)
Figure 71. Cipla Limited Revenue Growth Rate in Influenza Antiviral Drugs Business (2016-2021)
Figure 72. Natco Pharma Revenue Growth Rate in Influenza Antiviral Drugs Business (2016-2021)
Figure 73. Seqirus Revenue Growth Rate in Influenza Antiviral Drugs Business (2016-2021)
Figure 74. Adamas Pharmaceuticals, Inc. Revenue Growth Rate in Influenza Antiviral Drugs Business (2016-2021)
Figure 75. Teva Pharmaceuticals Revenue Growth Rate in Influenza Antiviral Drugs Business (2016-2021)
Figure 76. Daiichi Sankyo Company Revenue Growth Rate in Influenza Antiviral Drugs Business (2016-2021)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed

Global Influenza (Flu) Antiviral Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5801 2021年6月 121Pages
QYResearch社発行の本調査レポートでは、インフルエンザ (Flu) 抗ウイルス薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（浸透＆剥離阻害剤、DNAポリメラーゼ阻害剤、逆転写酵素阻害剤、タンパク質阻害剤、ノイラミニダーゼ阻害剤、広域スペ...

世界の新規抗ウイルス薬市場規模・現状・予測（2021年-2027年）

Global Novel Antiviral Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4596 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、新規抗ウイルス薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（逆転写酵素阻害剤、プロテアーゼ阻害剤、融合阻害剤、免疫系モジュレーター、その他）、用途別市場規模（肝炎治療、HIV/AIDS治療、ヘルペ...

世界の直接作用型抗ウイルス薬市場規模・現状・予測（2021年-2027年）

Global Direct-acting Antiviral Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4139 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、直接作用型抗ウイルス薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（NS3 / 4Aプロテアーゼ阻害剤、ヌクレオシド＆ヌクレオチドNS5Bポリメラーゼ阻害剤、NS5A阻害剤、非ヌクレオシドNS5Bポ...

世界の抗ウイルス療法市場規模・現状・予測（2021年-2027年）

Global Antiviral Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-3845 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、抗ウイルス療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ヘルペス抗ウイルス薬、肝炎抗ウイルス薬、HIV抗ウイルス薬、インフルエンザ抗ウイルス薬、その他）、用途別市場規模（病院、診療所、外来手術セ...

世界のインフルエンザ用治療薬市場規模・現状・予測（2021年-2027年）

Global Influenza Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5802 2021年6月 123Pages
QYResearch社発行の本調査レポートでは、インフルエンザ用治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（オセルタミビル、ザナミビル、ペラミビル、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、...

世界の犬インフルエンザ治療市場規模・現状・予測（2021年-2027年）

Global Canine Influenza Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3962 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、犬インフルエンザ治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、非ステロイド性抗炎症薬（NSAID）、抗ウイルス薬、その他）、用途別市場規模（獣医クリニック、獣医薬局、オンライン薬局、そ...

世界のインフルエンザ治療薬市場規模・現状・予測（2021年-2027年）

Global Influenza Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-4367 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、インフルエンザ治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ワクチン、医薬品）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、...

世界の呼吸器抗ウイルス治療市場規模・現状・予測（2021年-2027年）

Global Respiratory Antiviral Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4815 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、呼吸器抗ウイルス治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（インフルエンザ、細気管支炎、肺炎、上気道感染症（URTI）、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域...

世界の小児インフルエンザ治療市場規模・現状・予測（2021年-2027年）

Global Pediatric Influenza Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4674 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、小児インフルエンザ治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗ウイルス薬、解熱剤、ノイラミニダーゼ阻害剤、その他）、用途別市場規模（病院、クリニック、外来手術センター、その他）、主要地域別市...

世界の抗ウイルス経口液市場規模・現状・予測（2021年-2027年）

Global Antiviral Oral Liquid Market Size, Status and Forecast 2021-2027
QFJ1-3844 2021年6月 128Pages
QYResearch社発行の本調査レポートでは、抗ウイルス経口液の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（シロップ、経口懸濁液、経口液剤、経口滴剤、経口乳濁液、混合物）、用途別市場規模（大人用、子供用）、主要地域別市場規模（北米、アメリカ、欧...

世界のインフルエンザ (Flu) 抗ウイルス薬市場規模・現状・予測（2021年-2027年） Antiviral drugs are a class of drugs for the specific treatment of viral infections. Market Analysis and Insights: Global Influenza (Flu) Antiviral Drugs Market The global Influenza (Flu) Antiviral Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR…
世界のインフルエンザ用治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Influenza Drugs Market The global Influenza Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a bri…
世界の新規抗ウイルス薬市場規模・現状・予測（2021年-2027年） The mechanism of action of antiviral drugs is mainly to inhibit the entry of viral particles into host cells and to inhibit the early stages of viral replication. There is also an inhibitor of DNA polymerase, which is mainly due to its ability to inhibit viral coding. At present, new antiviral drugs…
世界の直接作用型抗ウイルス薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Direct-acting Antiviral Drugs Market The global Direct-acting Antiviral Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integ…
世界の抗ウイルス療法市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Antiviral Therapeutics Market The global Antiviral Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the repo…